Research Antibodies and Reagents Market is Probable to Influence the Value of USD 1921.14 Billion by 2030, Size, Share, Trends, Business Growth, Challenges and Competitive Outlook

Published June 12, 2023

Global Research Antibodies and Reagents Market research report contains most recent, ample and most advanced market information and a precious data. This global market report has been prepared with the combination of steps which employs a nice blend of industry insights, practical solutions, and latest tools and technologies. This market document gives out business purposes and endows with the best market research and analysis carried out with the advanced tools and techniques. Furthermore, the data is again checked and verified by the market experts before publishing it through Global Research Antibodies and Reagents Market report and providing it to the client.

Data Bridge Market Research analyses that the research antibodies and reagents market which was USD 1178.4 billion in 2022, is expected to reach USD 1921.14 billion by 2030, at a CAGR of 6.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @

Increased demand for high-quality antibodies for reproducible research will propel the market growth during the forecast period of 2023-2030. The market is also expanding as a result of the expanding landscape of proteomics and genomics research, as well as increased R&D efforts in the life sciences domain. Furthermore, the market is influenced by the rise of industry-academia collaborations and the expanding stem cell research and neurobiology research fields to meet unmet medical needs worldwide.

Market Overview:

Research antibodies and reagents are used to detect an unconjugated primary antibody, which is then used to target antigen. These products aid in the detection, measurement, and purification of proteins or biomolecules in a variety of applications such as flow cytometry, ELISA, western blotting, and immunohistochemistry.


  • Increased investment in medical and health R&D

Increased investment in medical and health R&D is expected to contribute to the research antibodies and reagents market growth. Antibodies and reagents are critical components in the investigation of biological processes or disease causes through careful experimentation, observation, laboratory work, analysis, and testing in the field of life science research. According to statistics published by the American Association for the Advancement of Science (AAAS) in December 2019, total investment in medical and health research in the United States increased by 6.4%. The health industry invested $129.5 billion (66.7%), followed by federal agencies’ investments of $43 billion (22.2%) and foundations, state and local governments, academic research institutions, and voluntary health associations’ investments of $21.7 billion (11.2%). Thus, rising investment in healthcare research and development sector will increase the utilization of research antibodies and reagents.

  • Increasing prevalence of neurodegenerative diseases

Antibodies are now one of the most important tools for research projects investigating the functions of various proteins in cells. The increasing prevalence of neurodegenerative diseases such as Huntington’s disease, Multiple Sclerosis, and Parkinson’s disease is fuelling research opportunities aimed at better understanding these diseases. Furthermore, the growing geriatric population and a scarcity of chronic disease treatments have contributed to a surge in demand for research antibodies to develop personalized medicines, cutting-edge pharmaceuticals, and novel and effective treatments.

Recent Developments

  • In October 2020, Centivac Inc, a contract research organization, announced a strategic agreement with Thermo Fisher Scientific to license the anti-covid-19 antibodies.

Some of the major players operating in the research antibodies and reagents market are:

  • General Electric (U.S.)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc. (U.S.)
  • F. Hoffmann La-Roche AG (Switzerland)
  • Rockland Immunochemicals Inc. (U.S.)
  • Johnson & Johnson private Limited (U.S.)
  • Agilent Technologies Inc. (U.S.)
  • Eli Lily and Company (U.S.)
  • BD (U.S.)
  • Danaher (U.S.)
  • PerkinElmer Inc. (U.S.)
  • GenScript Biotech Corporation (U.S.)
  • Lonza (Switzerland)
  • Bio-Techne Corporation (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Teva Pharmaceutical Industries Limited (Israel)
  • Santa Cruz Biotechnology Inc. (U.S.)
  • BioLegend Inc. (U.S.)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@

Global Research Antibodies and Reagents Market Scope


  • Reagents
  • Media and sera
  • Stains and dyes
  • Fixatives
  • Buffers
  • Solvents
  • Enzymes
  • Probes
  • Other reagents
  • Antibodies


  • Primary antibodies
  • Secondary antibodies


  • Monoclonal
  • polyclonal
  • Recombinant


  • Mice
  • Rabbits
  • Other sources

Research area

  • Oncology
  • Infectious diseases
  • Immunology
  • Neurobiology
  • Stem cells
  • Other research areas


  • Western Blotting
  • Flow Cytometry
  • Multiplex Immunosorbent Assay
  • Immunoprecipitation
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies


  • Proteomics
  • Drug Development
  • Genomics

End User

  • Pharmaceutical and Biotechnologies Industries
  • Academic and Research Institutions
  • Contract Research Organizations

Browse the complete table of contents at –

Research Antibodies and Reagents Market Regional Analysis/Insights

The research antibodies and reagents market is analysed and market size insights and trends are provided by country, product, technology, application and end user as referenced above.

The countries covered in the research antibodies and reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the research antibodies and reagents market because of an increase in investments for the development of structure-based drug designs, an emphasis on research projects involving proteins, associated biomolecules, and genes.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the surge in genomics and proteomics research and development activities.

Top DBMR Healthcare Reports:      

Research Antibodies Market – Industry Trends and Forecast to 2030

Recombinant Polyclonal Antibodies Market – Industry Trends and Forecast to 2029

Polyclonal Antibodies Market – Industry Trends and Forecast to 2029

Monoclonal Antibodies Market – Industry Trends and Forecast to 2029

Autoimmune Monoclonal Antibodies Market – Industry Trends and Forecast to 2029

Cancer Monoclonal Antibodies Market – Industry Trends and Forecast to 2029

Primary Antibodies Market – Industry Trends and Forecast to 2028

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


CDN Newswire